Prognostic significance of pre-treatment latent membrane protein 1 from nasopharyngeal swabs for stage III-IVA nasopharyngeal carcinoma.
Conclusion:Pre-treatment LMP1 as detected by nasopharyngeal swabs using PCR is an adverse prognostic factor for Stage III-IVA NPC, and potentially can be used as a treatment stratification tool.
Source: Head and Neck Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Carcinoma | Genetics | Nasopharyngeal Cancer | Radiation Therapy | Study